Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023, 24, 5869
Reference
- Titmuss, E.; Milne, K.; Jones, M.R.; Ng, T.; Topham, J.T.; Brown, S.D.; Schaeffer, D.F.; Kalloger, S.; Wilson, D.; Corbett, R.D.; et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023, 24, 5869. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Titmuss, E.; Milne, K.; Jones, M.R.; Ng, T.; Topham, J.T.; Brown, S.D.; Schaeffer, D.F.; Kalloger, S.; Wilson, D.; Corbett, R.D.; et al. Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023, 24, 5869. Int. J. Mol. Sci. 2024, 25, 12225. https://doi.org/10.3390/ijms252212225
Titmuss E, Milne K, Jones MR, Ng T, Topham JT, Brown SD, Schaeffer DF, Kalloger S, Wilson D, Corbett RD, et al. Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023, 24, 5869. International Journal of Molecular Sciences. 2024; 25(22):12225. https://doi.org/10.3390/ijms252212225
Chicago/Turabian StyleTitmuss, E., K. Milne, M. R. Jones, T. Ng, J. T. Topham, S. D. Brown, D. F. Schaeffer, S. Kalloger, D. Wilson, R. D. Corbett, and et al. 2024. "Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023, 24, 5869" International Journal of Molecular Sciences 25, no. 22: 12225. https://doi.org/10.3390/ijms252212225
APA StyleTitmuss, E., Milne, K., Jones, M. R., Ng, T., Topham, J. T., Brown, S. D., Schaeffer, D. F., Kalloger, S., Wilson, D., Corbett, R. D., Williamson, L. M., Mungall, K., Mungall, A. J., Holt, R. A., Nelson, B. H., Jones, S. J. M., Laskin, J., Lim, H. J., & Marra, M. A. (2024). Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023, 24, 5869. International Journal of Molecular Sciences, 25(22), 12225. https://doi.org/10.3390/ijms252212225